TME Pharma NV

11/11/2022 | Press release | Distributed by Public on 11/11/2022 05:59

TME Pharma announces publication of abstract disclosing positive interim results from bevacizumab expansion arm of NOX-A12 GLORIA Phase 1/2 brain cancer clinical trial[...]